Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Nephrology
•
Glomerulonephritis
What is your treatment approach for patients with crescentic IgA nephropathy who fail to respond to cyclophosphamide and steroids?
Related Questions
How often do you check fibrinogen levels and when do you administer FFP for patients with AKI requiring plasma exchange?
Do you extend the duration of maintenance therapy past 24 months for patients with ANCA glomerulonephritis who have multiple organ involvement?
How long do you continue maintenance immunosuppression in a patient with PR3 ANCA glomerulonephritis with pulmonary involvement?
Do you ever combine voclosporin and belimumab in the treatment of lupus nephritis?
Under what circumstances would you consider obinutuzumab instead of rituximab when treating primary membranous nephropathy?
How do you approach discussing the pill burden of voclosporin with patients who already have to take a regimen such as MMF+HCQ+ACEi and possibly more?
What is your preferred initial therapy for patients with IgA nephropathy and more than 1 gram of proteinuria, given the recent approvals of sparsentan and budesonide alongside existing options like prednisone and ACEi/ARBs?
Do you obtain spot urine protein or 24 hour urine protein quantification studies in pregnant patients who are found to have proteinuria on a standard urinalysis test?
What is your approach to the management of secondary membranous nephropathy with nephrotic range proteinuria?
How do you evaluate exercise induced hematuria that persists after one week of cessation of exercise?
